5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones: Novel Potent and Selective Dihydro-alkoxy-benzyl-oxopyrimidine Derivatives-Reference-Cited by-同舟云学术

5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones: Novel Potent and Selective Dihydro-alkoxy-benzyl-oxopyrimidine Derivatives

Published:1999-02-01 Issue:4 Volume:42 Page:619-627
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Mai Antonello¹,Artico Marino¹,Sbardella Gianluca¹,Massa Silvio¹,Novellino Ettore¹,Greco Giovanni¹,Loi Anna Giulia¹,Tramontano Enzo¹,Marongiu Maria Elena¹,La Colla Paolo¹

Affiliation:

1. Dipartimento di Studi Farmaceutici, Istituto Pasteur-Fondazione Cenci Bolognetti, Università degli Studi di Roma “La Sapienza”, P.le A. Moro 5, I-00185 Roma, Italy, Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Banchi di Sotto 55, I-53100 Siena, Italy, Dipartimento di Scienze Farmaceutiche, Università degli Studi di Salerno, P.za Vittorio Emanuele 9, I-84084 Penta (Salerno), Italy, Dipartimento di Chimica Farmaceutica e Tossicologica, Università degli Studi di Napoli...

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm980260f

Reference38 articles.

1. Toward Improved Anti-HIV Chemotherapy: Therapeutic Strategies for Intervention with HIV Infections

2. Antiviral therapy for human immunodeficiency virus infections

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of novel S-N3-DABO derivatives as potent non-nucleoside reverse transcriptase inhibitors with improved potency and selectivity;European Journal of Medicinal Chemistry;2023-02

2. An Epigenetic LINE-1-Based Mechanism in Cancer;International Journal of Molecular Sciences;2022-11-23

3. Structure-based linker optimization of 6-(2-cyclohexyl-1-alkyl)-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors;Chinese Chemical Letters;2021-03

4. Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years;Acta Pharmaceutica Sinica B;2020-06

5. Reverse transcriptase inhibitors promote the remodelling of nuclear architecture and induce autophagy in prostate cancer cells;Cancer Letters;2020-05